Alto Neuroscience, Inc

ANRONYSE · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

35.1M

on 2026-06-30, from 26.9M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

$300.0M

S-3 of 2025-02-03. 1 prospectus supplement filed under it since. S-3 ↗

$75.0M

Leerink Partners, agreement of 2025-02-03. No at-the-market sales statement read from a 10-Q or 10-K. S-3 ↗

Warrants

The 10-Q filed 2026-08-12 is not read yet.

Cash

14.3 quarters

$243.7M on 2026-06-30 ÷ $17.1M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-07-13	Public offering	3,776,436	$26.48	$100.0M	424B5 ↗